Indobufen vs aspirin for unruptured brain aneurysm treatment
Part of Brain & nervous system clinical trials.
This trial compares two anti-clotting drugs—indobufen and aspirin—to see which works better for people getting a stent or flow diverter for an unruptured brain aneurysm. The goal is to find which drug causes fewer bleeding or clotting problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a berry-shaped (saccular) brain aneurysm that hasn’t burst.
- You are scheduled for a procedure that uses a tiny tube (catheter) to place coils, a stent, or a flow diverter inside the aneurysm.
- You have not had a stroke, heart attack, or major bleeding in the last 6 months.
- You do not have a bleeding disorder or take strong blood thinners (other than aspirin or ibuprofen).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to treat a type of brain aneurysm (a weak spot in a blood vessel) that has not burst. It looks at early problems after using a flow diverter or stent-assisted coiling, to see which might be safer or more effective.
This trial tests a new device to block blood flow into unruptured brain aneurysms (balloon-like bulges). It is for adults whose aneurysm has not bled and fits specific size requirements. The goal is to see if the device is safe and works well.
This trial tests whether a blood thinner called indobufen works as well as aspirin for older people (65+) who have had a heart attack or unstable angina, received a drug-eluting stent, and are already taking two blood thinners. The goal is to find a safer or better option for long-term prevention.
This trial tests personalized blood thinner treatment for people who need long-term anticoagulation for conditions like atrial fibrillation or blood clots. The goal is to find the safest and most effective dose for each patient.
This study compares two combinations of blood thinners to see which works better for preventing clots after a stent procedure to treat an unruptured brain aneurysm. It is for people who have a specific gene test result that shows they process medicines normally.
This trial tests a new device called the World Diverter Embolization Device to treat brain aneurysms (a weak spot in a blood vessel that can bulge or burst). The device is placed inside the artery to block blood flow into the aneurysm. This study checks if the device is safe and works well.
Hear when a new Unruptured Intracranial Aneurysm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.